Piper Sandler downgraded MetLife Inc (MET) to Neutral from Overweight on September 18, 2025. The current price stands at $74.98.
This downgrade suggests increased caution regarding MetLife's outlook, potentially reflecting concerns about competitive pressures, market conditions, or execution risks that could impact performance.
MetLife, headquartered in New York City, provides insurance and financial services to individual and institutional customers. The company operates across various segments, including Group Benefits and Retirement and Income Solutions (RIS), and has a market capitalization of $49.9 billion. As of November 20, 2025, MetLife's price-to-earnings ratio is 13.00, with an earnings per share (EPS) of 5.62 and a dividend yield of 303.6%.
Upcoming earnings are scheduled for August 4, 2026, with an estimated EPS of $2.54 and revenue of $20.1 billion. Recent earnings performance showed Q3 2025 EPS at $2.37, exceeding estimates by 1.2%.
Analyst consensus as of November 1, 2025, includes 5 Strong Buy, 11 Buy, and 5 Hold ratings, with no Sell or Strong Sell ratings. This update provides insight into the shifting analyst perspectives on MetLife amid evolving market dynamics.